TMPRSS2 and prostate neoplasm: The present study was designed to assess the feasibility of an immunomagnetic enrichment method for detecting circulating prostate tumor cells using research prototype TMA assays for prostate-specific mRNAs (PSA, PCA3 and the TMPRSS2:ERG gene fusion).